James Warren

VP, Pharmaceutical Development, Ultragenyx Pharmaceutical Inc.

Biologics, Vaccine, and Viral Vector Product Development Leader, committed to improving global human health by systematically driving the advancement of new and improved medicines with sound science, clear strategy, and broad collaboration. 26 years of pharma and biotech industry experience and a broad background in both early and late stage vaccine, viral vector, cellular therapy, and biologics product development. Proficient in the development of cell culture processes and technology transfer strategies for vaccine, viral vector, and biologics products. Accomplished cross-functional CMC executive supporting critical paths to licensure of vaccine, viral vector, and biologics programs.